Immediate Impact

2 from Science/Nature 58 standout
Sub-graph 1 of 24

Citing Papers

Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants
2023 Standout
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
2021 Standout
2 intermediate papers

Works of G. Bánfi being referenced

Progressive improvement of patient and renal survival and reduction of morbidity over time in patients with lupus nephritis (LN) followed for 20 years
2013
The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study.
1991

Author Peers

Author Last Decade Papers Cites
G. Bánfi 516 249 289 40 1.1k
Andrew J. Aronson 336 209 234 21 908
G.S.C. Chiang 468 130 110 40 964
Aurélie Hummel 351 71 413 52 1.1k
Ashima Gulati 785 79 386 43 1.3k
Alberto Magnasco 619 94 127 37 1.0k
B. Hartley 420 126 116 27 971
F M Lai 420 277 171 30 854
Frank B. Cortazar 336 186 126 39 1.2k
R Waldherr 359 70 321 34 968
Patrizia Passerini 772 60 137 40 1.1k

All Works

Loading papers...

Rankless by CCL
2026